ArticleDermatology and therapy2025

Bimekizumab Efficacy in Psoriasis by Subgroups: Post Hoc Analysis of Phase 3/3b Clinical Trials.

Bruce Strober et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.